West Pharmaceutical Services, Inc. – Consensus ‘buy’ rating and 2.6% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

West Pharmaceutical Services, Inc. with ticker code (WST) now have 9 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 449 and 290 and has a mean target at $369.22. Given that the stocks previous close was at $360.02 this would indicate that there is a potential upside of 2.6%. It’s also worth noting that there is a 50 day moving average of $348.21 and the 200 moving average now moves to $287.32. The total market capitalization for the company now stands at 26.57B. The stock price is currently at: 355.18 USD

The potential market cap would be $27,246,153,034 based on the market consensus.

USD

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 48.86, revenue per share of 38.74 and a 13.22% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search